You have 9 free searches left this month | for more free features.

Selinexor

Showing 1 - 25 of 137

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • Selinexor
  • (no location specified)
Jul 31, 2023

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Suzhou (Selinexor, Chidamide)

Recruiting
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 16, 2023

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Selinexor
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Selinexor Combined With Lenalidomide and Rituximab in Treatment

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Selinexor combined with lenalidomide and rituximab
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 20, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Selinexor
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

Recruiting
  • Extensive-stage Small Cell Lung Cancer
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 27, 2023

PTCL Patients Who Achieved Complete Response From Frontline Treatment Trial (Selinexor)

Not yet recruiting
  • PTCL Patients Who Achieved Complete Response From Frontline Treatment
  • Selinexor
  • (no location specified)
Apr 18, 2023

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Selinexor
  • Wien, Austria
  • +1 more
Jul 13, 2023

Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,

Not yet recruiting
  • Rhabdoid Tumor
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 11, 2023

Multiple Myeloma Trial in West Hollywood, Cary (Selinexor, Placebo (for selinexor), carfilzomib)

Withdrawn
  • Multiple Myeloma
  • Selinexor
  • +3 more
  • West Hollywood, California
  • +1 more
Jan 24, 2023

Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

Not yet recruiting
  • Relapsed/Refractory AML
  • Selinexor
  • +6 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 28, 2023

EBV-Positive DLBCL, Nos Trial in Guangzhou, Shanghai (Selinexor, R-CHOP Protocol)

Recruiting
  • EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
  • Selinexor
  • R-CHOP Protocol
  • Guangzhou, Guangdong, China
  • +1 more
Nov 10, 2022

Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

Recruiting
  • Lymphoma
  • +2 more
  • Selinexor
  • Shanghai, Shanghai, China
  • +2 more
May 9, 2023

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • Selinexor
  • (no location specified)
Oct 27, 2022

Coronavirus Infection Trial (Selinexor)

Withdrawn
  • Coronavirus Infection
  • Selinexor
  • (no location specified)
Jan 19, 2023

Relapsed or Refractory B-cell Lymphoma Trial in Shanghai (SR-GDP)

Not yet recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • Shanghai, Shanhai, China
    Ruijin Hospital
Sep 29, 2023

Double Hit Lymphoma, Triple Hit Lymphoma Trial in Hangzhou (Selinexor+RCHOP)

Recruiting
  • Double Hit Lymphoma
  • Triple Hit Lymphoma
  • Hangzhou, Zhenjiang, China
    Zhejiang Cancer Hospital
Aug 2, 2023

Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Selinexor
  • +5 more
  • Taiyuan, Shanxi, China
    Tao Wang
Feb 9, 2023

Myeloma Multiple, Myeloma, Refractory Multiple Myeloma Trial in Brooklyn, New York (Selinexor, Clarithromycin, Pomalidomide)

Terminated
  • Myeloma Multiple
  • +2 more
  • Selinexor
  • +3 more
  • Brooklyn, New York
  • +1 more
Jan 24, 2023

DLBCL, Not Otherwise Specified Trial in Chongqing (selinexor)

Recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • selinexor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 27, 2023

Metastatic Colorectal Cancer Trial in Los Angeles, Newark, Plantation (Selinexor, Pembrolizumab, Trifluridine)

Terminated
  • Metastatic Colorectal Cancer
  • Selinexor
  • +3 more
  • Los Angeles, California
  • +2 more
Jan 24, 2023

Hepatocellular Carcinoma Trial in Tampa (Selinexor Pill, Bevacizumab, Atezolizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Selinexor Pill
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 16, 2022

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023